Skip to main content

and
  1. Article

    Open Access

    Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

    Clear cell renal cell carcinoma (ccRCC) is the dominant subtype of renal cancer. With currently available therapies, cure of advanced and metastatic ccRCC is achieved only in rare cases. Here, we developed a w...

    Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, Annika Nelde in Genome Medicine (2020)